253 related articles for article (PubMed ID: 15990754)
1. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
Silber S; Popma JJ; Suntharalingam M; Lansky AJ; Heuser RR; Speiser B; Teirstein PS; Bass T; O'Neill W; Lasala J; Reisman M; Sharma SK; Kuntz RE; Bonan R;
Am Heart J; 2005 Apr; 149(4):689-94. PubMed ID: 15990754
[TBL] [Abstract][Full Text] [Related]
2. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis.
Haase J; von Neumann-Cosel P; Damm M; Hofmann M; Störger H; Isner D; Bergmann M; Piancatelli C; Schächinger V; Schwarz F
Cardiovasc Revasc Med; 2005; 6(4):140-6. PubMed ID: 16326374
[TBL] [Abstract][Full Text] [Related]
4. Late and very late catch-up after 90Sr/90Y beta-irradiation for the treatment of coronary in-stent restenosis.
Schiele TM; Herbst J; Pöllinger B; Rieber J; König A; Sohn HY; Krötz F; Leibig M; Belka C; Klauss V
Acute Card Care; 2011 Mar; 13(1):9-13. PubMed ID: 21244228
[TBL] [Abstract][Full Text] [Related]
5. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
Suntharalingam M; Laskey W; Lansky AJ; Waksman R; White L; Teirstien P; Massullo V; Rutherford B; Elman A; Kuntz RE; Popma JJ; Bonan R
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1075-82. PubMed ID: 11958904
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
Popma JJ; Suntharalingam M; Lansky AJ; Heuser RR; Speiser B; Teirstein PS; Massullo V; Bass T; Henderson R; Silber S; von Rottkay P; Bonan R; Ho KK; Osattin A; Kuntz RE;
Circulation; 2002 Aug; 106(9):1090-6. PubMed ID: 12196334
[TBL] [Abstract][Full Text] [Related]
7. Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
Suntharalingam M; Laskey WK; Tantibhedhyangkul W; Lansky A; Teirstein P; Bass T; Silber S; Rutherford B; Wilmer C; Popma JJ; Kuntz R; Bonan R
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):536-42. PubMed ID: 12957267
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
[TBL] [Abstract][Full Text] [Related]
9. Late results (>10 years) of intracoronary beta brachytherapy for diffuse in-stent restenosis.
Seabra Gomes R; de Araújo Gonçalves P; Campante Teles R; de Sousa Almeida M
Rev Port Cardiol; 2014 Oct; 33(10):609-16. PubMed ID: 25304770
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Bunkheila F; Lombardo E; Pini S; Marrozzini C; Palmerini T; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
Catheter Cardiovasc Interv; 2004 Dec; 63(4):433-8. PubMed ID: 15558757
[TBL] [Abstract][Full Text] [Related]
11. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis.
Schukro C; Syeda B; Schmid R; Stemberger A; Lang I; Derntl M; Neunteufl T; Christ G; Kirisits C; Pokrajac B; Glogar D
Coron Artery Dis; 2004 Aug; 15(5):285-9. PubMed ID: 15238826
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary radiation therapy using a novel beta emitter for in-stent restenosis Tungsten WRIST.
Dilcher C; Satler LF; Pichard AD; Kent KM; Porrazzo M; Chan R; Torguson R; Canos DA; Waksman R
Cardiovasc Revasc Med; 2005; 6(2):52-7. PubMed ID: 16263359
[TBL] [Abstract][Full Text] [Related]
15. Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis.
Almeda FQ; Chua DY; Nathan S; Kim S; Meyer PM; Nguyen C; Chu JC; Kavinsky CJ; Snell RJ; Schaer GL
Catheter Cardiovasc Interv; 2003 Jun; 59(2):176-83. PubMed ID: 12772235
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary brachytherapy for the treatment of complex in-stent restenosis.
Cotton JM; Rance K; Patil A; Thomas MR
Heart; 2005 Feb; 91(2):231-2. PubMed ID: 15657245
[No Abstract] [Full Text] [Related]
18. Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practice.
Young JJ; Marcus DP; Abbottsmith CW; Broderick TM; Choo JK; Runyon JP; Schneider JF; Shimshak TM; Geier RP; Kereiakes DJ
J Invasive Cardiol; 2003 Jan; 15 Suppl A():9A-13A. PubMed ID: 12668834
[TBL] [Abstract][Full Text] [Related]
19. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
20. Angiographic and clinical outcomes at 8 months of cutting balloon angioplasty and beta-brachytherapy for native vessel in-stent restenosis (BETACUT): results from a stopped randomized controlled trial.
Schlüter M; Tübler T; Lansky AJ; Kähler S; Berger J; Mathey DG; Schofer J
Catheter Cardiovasc Interv; 2005 Nov; 66(3):320-6. PubMed ID: 16216024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
